Beam Therapeutics Secures $135 Million in Series B Financing to Advance Base Editing Platform and Expand Pipeline of Precision Genetic Medicines

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2tQ0kH4
via IFTTT